Taken together, these results suggest that restoring alveolar capillary barrier function, rather than enhancing alveolar fluid clearance, might be more important for ARDS treatment and account for the major mechanism by which the β1 subunit and MRCKα alone are mediating its effects on improved lung function and repair. This evidence concerns the gene CDC42BPA and acute respiratory distress syndrome.